
|Videos|September 2, 2015
Pharmacists and Future HRSA Policy Updates
Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.
Advertisement
Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.
This video was shot at ASHP's Summer Meetings and Exposition in Denver in June 2015.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Adds a New Sunscreen to the OTC Repertoire
2
EPCORE DLBCL-1 Trial Demonstrates Durable Responses, PFS Benefit With Epcoritamab in RR LBCL
3
NLA 2026: Evolocumab Cuts Cardiovascular Events in High-Risk Patients Before First MI or Stroke
4
From Confusion to Clarity: Nadia Ahmad, PharmD, Highlights the Vital Role of the 2026 OTC Guide
5






























































































































